NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Effect of Nicorandil in Type 2 Diabetic Obese Patients
Effect of Nicorandil in Type 2 Diabetic Obese Patients

NCT06423729

CompletedPhase 2

Sponsor: Tanta University

Conditions: Diabetes Mellitus, Type 2

Interventions: Nicorandil 10 MG

Countries: Egypt

1. Evaluating the effect of nicorandil on glycemic control of diabetic obese patients treated with sulfonylureas. 2. Investigating the effect of nicorandil on body weight of diabetic obese patients treated with sulfonylureas.

Eligibility overview

Sex: ALL

Age: 18 Years to 60 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Patients newly diagnosed with diabetes .
* Body mass index (BMI) \>30 Kg/m2.
* The selected patients are treated with sulfonylureas alone.
* The age of selected patient ranged from 18 and 60 years.

Exclusion Criteria:

* Pregnant and lactating females.
* Patients with hypersensitivity to nicorandil.
* Uncontrolled hypertension and its antihypertensive medications
* Severe renal or hepatic disease.
Locations (1)
  • Tanta, Egypt